Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Prostate Cancer Early Detection, Multi-Cancer Early Detection

Eric Klein

MD

🏢Cleveland Clinic / GRAIL🌐USA

Emeritus Chair Glickman Urological and Kidney Institute; Distinguished Scientist GRAIL

105
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Eric Klein is a leading urologic oncologist who led the SELECT chemoprevention trial and helped develop Oncotype DX for prostate cancer. He now leads clinical development activities for GRAIL's Galleri multi-cancer early detection test. He is emeritus chair at Cleveland Clinic's Glickman Institute.

Share:

🧪Research Fields 研究领域

prostate genomics
Oncotype DX prostate
SELECT trial
Galleri MCED
circulating tumor DNA

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Eric Klein 的研究动态

Follow Eric Klein's research updates

留下邮箱,当我们发布与 Eric Klein(Cleveland Clinic / GRAIL)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment